Due to the coronavirus pandemic in the world, many companies have found it difficult to comply with certain requirements set out in ANVISA Resolutions 47/09 and 71/09, related to the labeling and instructions for medications. To try to minimize the impact, ANVISA published RDC No. 400/20, making non-compliance possible, as long as the emergency situation declared by Ordinance No. 188/2020 of the Ministry of Health endures.
This content is available only in Portuguese. Find out more here.